Skip to content
Screener

Revvity RVTY Total Liabilities

Total Liabilities at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$767M
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$4.24B+2.9%
WAT
Waters CorporationWAT
$9.56B+274%
Agilent Technologies logo
Agilent TechnologiesA
$5.94B-1.3%
Illumina logo
IlluminaILMN
$186M
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$2.94B+3.2%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$12.83B+28.7%
Enterprise value$15.91B+28.6%
P/E53.5×+18.6×
P/S4.4×+0.9×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: Revvity’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000031791-26-000019
Line itemApril 5,2026December 28,2025
Long-term debt2,632,0722,631,236
Deferred taxes and other long-term liabilities800,859807,461
Operating lease liabilities142,276148,108
Total liabilities4,813,8514,918,051
Commitments and contingencies (see Note 14)
Stockholders’ equity:
Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding
Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 111,629,000 shares and 112,281,000 shares at April 5, 2026 and December 28, 2025, respectively111,629112,281

Item 1.Unaudited Financial Statements

FAQ

What is Revvity's total liabilities?
Revvity (RVTY) reported total liabilities of $4.81B in Q1 2026.
How has Revvity's total liabilities changed year-over-year?
Revvity's total liabilities increased by 1.9% year-over-year, from $4.72B to $4.81B.
What is the long-term trend for Revvity's total liabilities?
Over 5 years (2020 to 2025), Revvity's total liabilities has grown at a 3.1% compound annual growth rate (CAGR), from $4.22B to $4.92B.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Ask your AI about Revvity's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude